17 July 2026: An extraordinary general meeting of Aker BioMarine ASA will be held on 17 August 2026 at 09:00 CEST. The meeting will be conducted as a virtual meeting only, and voting will be handled online during the meeting. Information about log-in details for the meeting is available in the notice of the general meeting. For further information regarding participation, please go to www.akerbiomarine/agm. No pre-registration is needed for attending online, but attendees must be logged in before the meeting starts. Deadline for registration of advance votes and proxies is 14 August 2026 at 16:00 CEST. Please find attached the following documents - Notice and Proxy forms for the Extraordinary General Meeting - Proposed Resolutions for the Extraordinary General Meeting All documents to be processed in the meeting are available on www.akerbiomarine/agm. For further information, please contact Lars Jacobsen, General Counsel Mobile: +47 906 05 306 Email: lars.jacobsen@akerbiomarine.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Click here for more information
© Oslo Bors ASA, source Oslo Stock Exchange